United States · FDA National Drug Code directory

ciprofloxacin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
54348-663_ea938ef9-a316-2003-e053-2a95a90aa829
Product NDC
54348-663
Form
TABLET
Composition / generic term
CIPROFLOXACIN
Labeler
PharmPak, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20190710
Source listing expiry
20261231

Source-listed ingredients

  • CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 BOX (54348-663-01) / 1 TABLET in 1 BOTTLE · 54348-663-01
  • 1 BOTTLE in 1 BOX (54348-663-06) / 6 TABLET in 1 BOTTLE · 54348-663-06
  • 1 BOTTLE in 1 BOX (54348-663-14) / 14 TABLET in 1 BOTTLE · 54348-663-14

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →